A new era in blood and lymphatic cancer biology and therapy
David DingliDivision of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN, USATumors derived from the transformation of hematopoietic or lymphoid cells are increasing in incidence1 and with improvements in therapy, their prevalence is also growing. The increasing availabilit...
Guardado en:
Autor principal: | David Dingli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e50a58f82d344c4a927cbc79ab987b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood and Lymphatic Cancer: Targets and Therapy
Publicado: (2012) -
SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
por: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publicado: (2021) -
EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C
por: Fatma Burçin KURTİPEK, et al.
Publicado: (2021) -
INTRAPLEURAL THERAPY TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
por: Vera S. Donnenberg, PhD, FCP, et al.
Publicado: (2021) -
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
por: Fatma YILMAZ, et al.
Publicado: (2021)